Are you Dr. Follett?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 59 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
988102 Nebraska Medical Ctr
Omaha, NE 68198Phone+1 402-559-8600Fax+1 402-559-5010
Summary
- Dr. Kenneth Follett, MD is a neurosurgeon in Omaha, Nebraska. He is currently licensed to practice medicine in Nebraska, Illinois, and Iowa. He is affiliated with Nebraska Methodist Hospital and Nebraska Medicine - Nebraska Medical Center.
Education & Training
University of Iowa Hospitals and ClinicsResidency, Neurological Surgery, 1984 - 1990
University of Nebraska College of MedicineClass of 1983
Certifications & Licensure
NE State Medical License 1983 - 2021
IA State Medical License 1984 - 2006
IL State Medical License 1987 - 1990- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FAANS) American Association of Neurological Surgeons
Clinical Trials
- Phase I Deep Brain Stimulation (DBS) vs. Best Medical Therapy (BMT) Trial Start of enrollment: 2002 Apr 01
- Phase II Subthalamic Nucleus (STN) vs. Globus Pallidus (GPi) Trial Start of enrollment: 2002 Apr 01
Publications & Presentations
PubMed
- 19 citationsComparing two randomized deep brain stimulation trials for Parkinson's disease.Günther Deuschl, Kenneth A. Follett, Ping Luo, Joern Rau, Frances M. Weaver
Journal of Neurosurgery. 2020-05-01 - 7 citationsHealthcare Utilization and Costs for Patients With Parkinson's Disease After Deep Brain Stimulation.Kevin T. Stroupe, Bridget Smith, Frances M. Weaver, Beverly Gonzalez, Zhiping Huo
Movement Disorders Clinical Practice. 2019-06-01 - 2 citationsAssociation of Preoperative Diagnosis with Clinical Yield of Muscle Biopsy.Steven Tenny, Kyle P Schmidt, Kenneth A. Follett
Cureus. 2018-10-14
Press Mentions
DEA and Schedule II “Do Not Fill Prescriptions”— Disappointing Enforcement ActivityMarch 9th, 2006- Pain, the DEA, and the Impact on PatientsJanuary 1st, 2006
Professional Memberships
- Member
- Member
- Fellow
